ALGN
Price
$128.18
Change
-$0.82 (-0.64%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
9.35B
35 days until earnings call
NVST
Price
$20.78
Change
-$0.06 (-0.29%)
Updated
Sep 24, 12:18 PM (EDT)
Capitalization
3.46B
35 days until earnings call
Interact to see
Advertisement

ALGN vs NVST

Header iconALGN vs NVST Comparison
Open Charts ALGN vs NVSTBanner chart's image
Align Technology
Price$128.18
Change-$0.82 (-0.64%)
Volume$10.14K
Capitalization9.35B
Envista Holdings
Price$20.78
Change-$0.06 (-0.29%)
Volume$500
Capitalization3.46B
ALGN vs NVST Comparison Chart in %
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. NVST commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a StrongBuy and NVST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (ALGN: $129.00 vs. NVST: $20.84)
Brand notoriety: ALGN: Notable vs. NVST: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALGN: 55% vs. NVST: 96%
Market capitalization -- ALGN: $9.35B vs. NVST: $3.46B
ALGN [@Pharmaceuticals: Other] is valued at $9.35B. NVST’s [@Pharmaceuticals: Other] market capitalization is $3.46B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $160.51B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileNVST’s FA Score has 0 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • NVST’s FA Score: 0 green, 5 red.
According to our system of comparison, NVST is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 4 TA indicator(s) are bullish while NVST’s TA Score has 4 bullish TA indicator(s).

  • ALGN’s TA Score: 4 bullish, 3 bearish.
  • NVST’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both ALGN and NVST are a good buy in the short-term.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а -2.14% price change this week, while NVST (@Pharmaceuticals: Other) price change was -1.23% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.28%. For the same industry, the average monthly price growth was -1.82%, and the average quarterly price growth was +9.28%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 29, 2025.

NVST is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.28% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($9.35B) has a higher market cap than NVST($3.46B). NVST has higher P/E ratio than ALGN: NVST (65.13) vs ALGN (21.79). NVST YTD gains are higher at: 8.035 vs. ALGN (-38.132). ALGN has higher annual earnings (EBITDA): 793M vs. NVST (303M). NVST has more cash in the bank: 1.11B vs. ALGN (901M). ALGN has less debt than NVST: ALGN (123M) vs NVST (1.6B). ALGN has higher revenues than NVST: ALGN (3.97B) vs NVST (2.55B).
ALGNNVSTALGN / NVST
Capitalization9.35B3.46B270%
EBITDA793M303M262%
Gain YTD-38.1328.035-475%
P/E Ratio21.7965.1333%
Revenue3.97B2.55B155%
Total Cash901M1.11B81%
Total Debt123M1.6B8%
FUNDAMENTALS RATINGS
ALGN vs NVST: Fundamental Ratings
ALGN
NVST
OUTLOOK RATING
1..100
5465
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6691
PRICE GROWTH RATING
1..100
6552
P/E GROWTH RATING
1..100
9446
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALGN's Valuation (73) in the Medical Specialties industry is in the same range as NVST (73) in the null industry. This means that ALGN’s stock grew similarly to NVST’s over the last 12 months.

ALGN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVST (100) in the null industry. This means that ALGN’s stock grew similarly to NVST’s over the last 12 months.

ALGN's SMR Rating (66) in the Medical Specialties industry is in the same range as NVST (91) in the null industry. This means that ALGN’s stock grew similarly to NVST’s over the last 12 months.

NVST's Price Growth Rating (52) in the null industry is in the same range as ALGN (65) in the Medical Specialties industry. This means that NVST’s stock grew similarly to ALGN’s over the last 12 months.

NVST's P/E Growth Rating (46) in the null industry is somewhat better than the same rating for ALGN (94) in the Medical Specialties industry. This means that NVST’s stock grew somewhat faster than ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNNVST
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
63%
MACD
ODDS (%)
Bullish Trend 6 days ago
73%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 20 days ago
75%
Bullish Trend 20 days ago
66%
Declines
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
61%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RPV98.650.94
+0.96%
Invesco S&P 500® Pure Value ETF
ELC21.68-0.10
-0.44%
Entergy Louisiana LLC
SXQG33.37-0.25
-0.74%
ETC 6 Meridian Quality Growth ETF
EKG17.41-0.19
-1.08%
First Trust Nasdaq Lux Dgtl Hlth SoluETF
TBT34.05-0.44
-1.28%
ProShares UltraShort 20+ Year Treasury

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been loosely correlated with BAX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGN jumps, then BAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
-1.66%
BAX - ALGN
62%
Loosely correlated
+0.22%
JNDOF - ALGN
60%
Loosely correlated
N/A
LUNG - ALGN
54%
Loosely correlated
-1.09%
ITGR - ALGN
44%
Loosely correlated
-0.48%
NVST - ALGN
43%
Loosely correlated
-0.24%
More

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with A. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
-0.24%
A - NVST
57%
Loosely correlated
-0.31%
MTD - NVST
56%
Loosely correlated
-0.08%
SOLV - NVST
55%
Loosely correlated
-0.50%
XRAY - NVST
55%
Loosely correlated
-2.11%
BIO - NVST
53%
Loosely correlated
-0.46%
More